Skip to Main Content

Clinical Studies and Protocols

Site Map Investigators Log-in
(MCA-0906) 3BNC117 and 10-1074 in HIV-infected individuals


 Return to List of Clinical Studies
 Return to List of Protocols for HIV and AIDS
An phase 1b study of the safety, pharmacokinetics and antiretroviral activity of the combination of 3BNC117 and 10-1074 in HIV-infected individuals.

Principal Investigator:
Marina Caskey M.D.

Investigators:

Contact Information:
Recruitment Specialist
1230 York Avenue
New York, NY 10065
Telephone: 1800RUCARES
Email: RUCARES@Rockefeller.edu
Enrollment Status:
Open to Enrollment

Brief Summary of Protocol:




Detailed Description of Protocol:




What specifically makes a person eligible for the study?
You may be eligible to enter this study:

-Age 18 to 65. -HIV positive -Hepatitis B and C negative

Gender:
Both

Age(s):
18-65

Children permitted to participate:
No

Potential Benefits.....




Compensation:
Compensation is provided